Dalila Hamami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dalila Hamami has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Baghdad Atmani
Computer Science Laboratory of Oran (LIO) Department of Computer Science University of Oran El M'Naouer Es Senia BP 1524 31 000 Oran Algeria
2 shared publications Carron Shankland
Department of Computing Science and Mathematics, University of StirlingStirling, UK
2 shared publications- Carron Shankland
University of Stirling
2 shared publications Atmani Baghdad
Laboratoire d'informatique d'Oran (LIO), University of Oran 1 Ahmed Benbella, Oran, Algeria
1 shared publicationBaghdad Atmani
University of Oran 1 Ahmed Ben Bella
1 shared publication- David Cairns
University of Stirling, Stirling, United Kingdom
1 shared publication
Latest Publications
- 10 December 2020
- Published by Springer Nature
- p. 19-32
Effective Use of Evolutionary Computation to Parameterise an Epidemiological Model
- 10 December 2020
- Published by Springer Nature
- p. 19-32
Effective Use of Evolutionary Computation to Parameterise an Epidemiological Model
- 22 July 2017
- Published by Springer Nature in Journal of Intelligent Information Systems
- Vol. 52 (3) , 477-499
Improving process algebra model structure and parameters in infectious disease epidemiology through data mining
- 22 July 2017
- Published by Springer Nature in Journal of Intelligent Information Systems
- Vol. 52 (3) , 477-499
Improving process algebra model structure and parameters in infectious disease epidemiology through data mining
- Open Access
- 25 April 2017
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 8, 233
Waning Immunity Is Associated with Periodic Large Outbreaks of Mumps: A Mathematical Modeling Study of Scottish Data
Vaccination programs for childhood diseases, such as measles, mumps and rubella have greatly contributed to decreasing the incidence and impact of those diseases. Nonetheless, despite long vaccination programmes across the world, mumps has not yet been eradicated in those countries: indeed, large outbreaks continue. For example, in Scotland large outbreaks occurred in 2004, 2005 and 2015, despite introducing the MMR (Measles- Mumps- Rubella) vaccine more than twenty years ago. There are indications that this vaccine-preventable disease is re-emerging in highly vaccinated populations. Here we investigate whether the resurgence of mumps is due to waning immunity, and further, could a booster dose be the solution to eradicate mumps or would it just extend the period of waning immunity? Using mathematical modelling we enhance a seasonally-structured disease model with four scenarios: no vaccination, vaccinated individuals protected for life, vaccinated individuals at risk of waning immunity, and introduction of measures to increase immunity (a third dose, or a better vaccine). The model is parameterised from observed clinical data in Scotland 2004-2015 and the literature. The results of the four scenarios are compared with observed clinical data 2004-2016. While the force of infection is relatively sensitive to the duration of immunity and the number of boosters undertaken, we conclude that periodic large outbreaks of mumps will be sustained for all except the second scenario. This suggests that the current protocol of two vaccinations is optimal in the sense that while there are periodic large outbreaks, the severity of cases in vaccinated individuals is less than in unvaccinated individuals, and the size of the outbreaks does not decrease sufficiently with a third booster to make economic sense. This recommendation relies on continuous efforts to maintain high levels of vaccination uptake.
- 25 April 2017
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 8, 233
Open AccessWaning Immunity Is Associated with Periodic Large Outbreaks of Mumps: A Mathematical Modeling Study of Scottish Data
Vaccination programs for childhood diseases, such as measles, mumps and rubella have greatly contributed to decreasing the incidence and impact of those diseases. Nonetheless, despite long vaccination programmes across the world, mumps has not yet been eradicated in those countries: indeed, large outbreaks continue. For example, in Scotland large outbreaks occurred in 2004, 2005 and 2015, despite introducing the MMR (Measles- Mumps- Rubella) vaccine more than twenty years ago. There are indications that this vaccine-preventable disease is re-emerging in highly vaccinated populations. Here we investigate whether the resurgence of mumps is due to waning immunity, and further, could a booster dose be the solution to eradicate mumps or would it just extend the period of waning immunity? Using mathematical modelling we enhance a seasonally-structured disease model with four scenarios: no vaccination, vaccinated individuals protected for life, vaccinated individuals at risk of waning immunity, and introduction of measures to increase immunity (a third dose, or a better vaccine). The model is parameterised from observed clinical data in Scotland 2004-2015 and the literature. The results of the four scenarios are compared with observed clinical data 2004-2016. While the force of infection is relatively sensitive to the duration of immunity and the number of boosters undertaken, we conclude that periodic large outbreaks of mumps will be sustained for all except the second scenario. This suggests that the current protocol of two vaccinations is optimal in the sense that while there are periodic large outbreaks, the severity of cases in vaccinated individuals is less than in unvaccinated individuals, and the size of the outbreaks does not decrease sufficiently with a third booster to make economic sense. This recommendation relies on continuous efforts to maintain high levels of vaccination uptake.
- 1 April 2017
- Published by IGI Global Scientific Publishing in International Journal of Information Systems in the Service Sector
- Vol. 9 (2) , 71-101
Decision Support based on Bio-PEPA Modeling and Decision Tree Induction
The problem of selecting determinant features generating appropriate model structure is a challenge in epidemiological modelling. Disease spread is highly complex, and experts develop their understanding of its dynamic over years. There is an increasing variety and volume of epidemiological data which adds to the potential confusion. The authors propose here to make use of that data to better understand disease systems. Decision tree techniques have been extensively used to extract pertinent information and improve decision making. In this paper, the authors propose an innovative structured approach combining decision tree induction with Bio-PEPA computational modelling, and illustrate the approach through application to tuberculosis. By using decision tree induction, the enhanced Bio-PEPA model shows considerable improvement over the initial model with regard to the simulated results matching observed data. The key finding is that the developer expresses a realistic predictive model using relevant features, thus considering this approach as decision support, empowers the epidemiologist in his policy decision making.
- 1 April 2017
- Published by IGI Global Scientific Publishing in International Journal of Information Systems in the Service Sector
- Vol. 9 (2) , 71-101
Decision Support based on Bio-PEPA Modeling and Decision Tree Induction
The problem of selecting determinant features generating appropriate model structure is a challenge in epidemiological modelling. Disease spread is highly complex, and experts develop their understanding of its dynamic over years. There is an increasing variety and volume of epidemiological data which adds to the potential confusion. The authors propose here to make use of that data to better understand disease systems. Decision tree techniques have been extensively used to extract pertinent information and improve decision making. In this paper, the authors propose an innovative structured approach combining decision tree induction with Bio-PEPA computational modelling, and illustrate the approach through application to tuberculosis. By using decision tree induction, the enhanced Bio-PEPA model shows considerable improvement over the initial model with regard to the simulated results matching observed data. The key finding is that the developer expresses a realistic predictive model using relevant features, thus considering this approach as decision support, empowers the epidemiologist in his policy decision making.
- 2 October 2016
- Published by Springer Nature
- p. 62-75
Obtaining Optimal Bio-PEPA Model Using Association Rules: Approach Applied to Tuberculosis Case Study
- 2 October 2016
- Published by Springer Nature
- p. 62-75
Obtaining Optimal Bio-PEPA Model Using Association Rules: Approach Applied to Tuberculosis Case Study
- Open Access
SBML for optimizing decision support's tools
Many theoretical works and tools on epidemiological field reflect the emphasis on decision-making Tools by both public health and the scientific community, which continues to increase. Indeed, in the epidemiological field, modeling tools are proving a very important way in helping to make decision. However, the variety, the large volume of data and the nature of epidemics lead us to seek solutions to alleviate the heavy burden imposed on both experts and developers. In this paper, we present a new approach: the passage of an epidemic model realized in Bio-PEPA to a narrative language using the basics of SBML language. Our goal is to allow on one hand, epidemiologists to verify and validate the model, and the other hand, developers to optimize the model in order to achieve a better model of decision making. We also present some preliminary results and some suggestions to improve the simulated model.
Open AccessSBML for optimizing decision support's tools
Many theoretical works and tools on epidemiological field reflect the emphasis on decision-making Tools by both public health and the scientific community, which continues to increase. Indeed, in the epidemiological field, modeling tools are proving a very important way in helping to make decision. However, the variety, the large volume of data and the nature of epidemics lead us to seek solutions to alleviate the heavy burden imposed on both experts and developers. In this paper, we present a new approach: the passage of an epidemic model realized in Bio-PEPA to a narrative language using the basics of SBML language. Our goal is to allow on one hand, epidemiologists to verify and validate the model, and the other hand, developers to optimize the model in order to achieve a better model of decision making. We also present some preliminary results and some suggestions to improve the simulated model.